Keywords: نئوپلاسم پروستات; prostatic neoplasms; brachytherapy; ulcer; fistula; iatrogenic disease; ADT; androgen deprivation therapy; APC; argon plasma coagulation therapy; IBD; inflammatory bowel disease; LDR; low dose rate; NCCN®; National Comprehensive Cancer Network®; PB; pro
مقالات ISI نئوپلاسم پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نئوپلاسم پروستات; prostatic neoplasms; radiotherapy; dose-response relationship; radiation; brachytherapy; mortalityADT, androgen deprivation therapy; ASCENDE-RT, Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy; DE, dose-escalated; GS
Keywords: نئوپلاسم پروستات; treatment outcome; prostatectomy; prostatic neoplasms; robotics; mortalityAJCC, American Joint Committee on Cancer; BCR, biochemical recurrence; CCI, Charlson comorbidity index; LOS, length of stay; NCDB, National Cancer Data Base; ORP, open radical prost
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; neoplasm metastasis; risk factors; neoplasm gradingADT, androgen deprivation therapy; AS, active surveillance; DT, doubling time; GP, Gleason pattern; GS, Gleason score; PSA, prostate specific antigen; RP, radical pr
Keywords: نئوپلاسم پروستات; biopsy; prevalence; prostatic neoplasms; risk assessmentMCCL, maximum cancer core length; PSA, prostate specific antigen; TPM, template prostate mapping; TRUS, transrectal ultrasound; UCL, University College London; UK, United Kingdom
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biopsy; watchful waitingAS, active surveillance; DWI, diffusion weighted imaging; MR, magnetic resonance; MRI, magnetic resonance imaging; PSA, prostate specific antigen; T2WI, T2-weighted images
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biopsy; magnetic resonance imaging; neoplasm gradingDCE, dynamic contrast enhanced; DW, diffusion weighted; mp, multiparametric; MRI, magnetic resonance imaging; RP, radical prostatectomy; T2W, T2-weighted; TB, targeted biopsy; TRUS,
Keywords: نئوپلاسم پروستات; prostatic neoplasms; comorbidity; neoplasm grading; neoplasm staging; watchful waitingCCI, Charlson comorbidity index; NCDB, National Cancer Data Base; PC, prostate cancer; PSA, prostate specific antigen; UGUS, upgrading and/or up staging
Keywords: نئوپلاسم پروستات; antineoplastic agents, hormonal; costs and cost analysis; prostatic neoplasms; neoplasm metastasis; orchiectomy; ADT; androgen deprivation therapy; BSO; bilateral simple orchiectomy; ESO; epididymal sparing orchiectomy; LHRH; luteinizing hormone-releasing
Keywords: نئوپلاسم پروستات; Diagnostic test accuracy; Imaging test; Partin table; Prostatic neoplasms; Risk assessment;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; magnetic resonance imaging; prostate-specific antigen; biopsy; mass screeningDRE, digital rectal examination; FOV, field of view; MRI, magnetic resonance imaging; NEX, number of excitations; NPV, negative predictive value; PPV, positi
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; diagnosis; biopsyCV, coefficient of variation; DRE, digital rectal examination; PSA, prostate specific antigen; SABOR, San Antonio Biomarkers of Risk of Prostate Cancer Study
Keywords: نئوپلاسم پروستات; Gleason score; Humans; Prognosis; Risk assessment; Prostatectomy; Tumor volume; Neoplasm grading; Neoplasm recurrence; Prostatic neoplasms;
Keywords: نئوپلاسم پروستات; survival rate; prostatic neoplasms; prostatectomy; age factors; familyPSA, prostate specific antigen
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; neoplasm gradingBCR, biochemical recurrence; F-EPE, focal extraprostatic extension; GS, Gleason score; LN, lymph node; NF-EPE, nonfocal extraprostatic extension; OC, organ confined; PM, positive surgical margin; PSA, pr
Keywords: نئوپلاسم پروستات; Early detection of cancer; Risk assessment; Prostatic Neoplasms; Biopsy; Magnetic Resonance Imaging;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; tumor burden; neoplasm grading; biopsy; watchful waiting5ARI, 5α-reductase inhibitor; AS, active surveillance; B1, diagnostic biopsy (biopsy 1); B2, confirmatory biopsy (biopsy 2); B3, biopsy 3 (from diagnostic); B4, biopsy 4; GS, Gle
Keywords: نئوپلاسم پروستات; prostate-specific antigen; prostatic neoplasms; African Americans; European continental ancestry group; neoplasm gradingAA, African-American; BMI, body mass index; ISUP, International Society of Urological Pathology; NCCN®, National Comprehensive Cancer N
Keywords: نئوپلاسم پروستات; urinary incontinence; laparoscopy; prostatic neoplasms; roboticsEPIC, Expanded Prostate Cancer Index Composite; RARP, robot-assisted radical prostatectomy; SIS, small intestinal submucosa
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; aged; aged, 80 and over; outcome assessment, (health care)ADT, androgen deprivation therapy; ASA®, American Society of Anesthesiologists®; BCR, biochemical recurrence; LE, life expectancy; PCa, prostate cancer; PSA, pro
Keywords: نئوپلاسم پروستات; prostatectomy; robotics; prostatic neoplasms; MIRP; minimally invasive radical prostatectomy; NCI; National Cancer Institute; ORP; open radical prostatectomy; RP; radical prostatectomy;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; watchful waiting; risk; outcome assessment (health care)AS, active surveillance; BCR, biochemical recurrence; BMI, body mass index; GS, Gleason score; HP, high PSA; IP, intermediate PSA; LP, low PSA; PCa, pr
Keywords: نئوپلاسم پروستات; Health care quality, access, and evaluation; prostatic neoplasms; prostatectomy; radiation oncology; radiotherapy, adjuvant;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; patient preference; quality of life; questionnaires; decision making; AUA; American Urological Association; DA; decision aid; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; EPI
Keywords: نئوپلاسم پروستات; watchful waiting; prostatic neoplasms; quality of life; survival rate; image-guided biopsyAS, active surveillance; CPDR, Center for Prostate Disease Research; EPIC, Expanded Prostate Cancer Index Composite; HRQoL, health related quality of life; PCa, pros
Keywords: نئوپلاسم پروستات; prostatic neoplasms; age groups; mortality; prostate cancer; riskCCI, Charlson comorbidity index; CSM, cancer specific mortality; OCM, other cause mortality; PCa, prostate cancer; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: نئوپلاسم پروستات; prostate-specific antigen; prostatic neoplasms; recurrence; prostatectomy; BCR; biochemical recurrence; LOQ; limit of quantitation; PSA; prostate specific antigen; RP; radical prostatectomy;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; neoplasm recurrence, local; magnetic resonance imaging; diagnostic imaging; prognosisAPC, anterior prostate cancer; BCR, biochemical recurrence; DRE, digital rectal examination; ECE, extracapsular extension; LNI, lymph node involvemen
Keywords: نئوپلاسم پروستات; biopsy; prostatic neoplasms; prostatectomy; recurrence; neoplasm gradingADT, androgen deprivation therapy; BCR, biochemical recurrence; G4%, percent Gleason pattern 4 involvement; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; erectile dysfunctionADT, androgen deprivation therapy; BCR, biochemical recurrence; ED, erectile dysfunction; EPE, extraprostatic extension; IIEF-6, International Index of Erectile Function; MRI, magnetic resonance imag
Keywords: نئوپلاسم پروستات; magnetic resonance imaging; prostatic neoplasms; watchful waitingADC, apparent diffusion coefficient; AS, active surveillance; MCCL, maximum cancer core length; mpMRI, multiparametric magnetic resonance imaging; MRI, magnetic resonance imaging; MR-US, mag
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; risk factors; mass screeningERSPC, European Randomized Study of Screening for Prostate Cancer; PCa, prostate cancer; PSA, prostate specific antigen
Keywords: نئوپلاسم پروستات; prostatic neoplasms; SEER program; United States/epidemiology; watchful waiting; early detection of cancer; BLS; Bureau of Labor Statistics; CM; conservative management; CPI; Consumer Price Index; NCCN®; National Comprehensive Cancer Network®; PCa; pros
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; magnetic resonance imaging; image-guided biopsyAS, active surveillance; GU, genitourinary; mp, multiparametric; MRI, magnetic resonance imaging; ROI, regions of interest; TRUS, transrectal ultrasound
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; early detection of cancer; government agencies; biopsy; needle; AUA; American Urological Association; AUASS; AUA symptom score; CAPRA; Cancer of the Prostate Risk Assessment; PCa; prostate cancer; PCP; prima
Keywords: نئوپلاسم پروستات; fistula; pubic symphysis; radiotherapy; prostatic neoplasms; complicationsBNC, bladder neck contracture; EBRT, external beam radiotherapy; HIFU, high intensity focused ultrasound; MRI, magnetic resonance imaging; RP, radical prostatectomy; TURP, transuret
Keywords: نئوپلاسم پروستات; Androgen deprivation therapy; Adverse effects; Prostatic neoplasms; Survey;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; magnetic resonance imaging; early detection of cancer; biopsy; prostate-specific antigenDRE, digital rectal examination; mp, multiparametric; MRI, magnetic resonance imaging; NPV, negative predictive value; PC, prostate cancer; PI-RAD
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biological markers; sensitivity and specificity; prostate-specific antigen; risk; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; CCP; cell cycle progression; DRE; di
Keywords: نئوپلاسم پروستات; prostatic neoplasms; genomics; biological assay; prostatectomy; watchful waiting; AP; adverse pathology; AS; active surveillance; CAPRA; Cancer of the Prostate Risk Assessment; GPS; Genomic Prostate Score; LFP; likelihood of favorable pathology; LIR; low
Keywords: نئوپلاسم پروستات; prostatic neoplasms; genomics; biological assay; AS; active surveillance; GPS; Genomic Prostate Score; NCCN®; National Comprehensive Cancer Network®; PCa; prostate cancer; PSA; prostate specific antigen;
Keywords: نئوپلاسم پروستات; costs and cost analysis; urinary bladder neoplasms; kidney neoplasms; prostatic neoplasms; postoperative complications; IVC; inferior vena cava;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Diffusion-weighted MRI; Nomograms;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Prostatectomy; Retropubic; Brachytherapy; Computer-assisted radiotherapy; Intensity-modulated radiotherapy;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Brachytherapy; Radiotherapy; Prostatectomy; Retropubic; Survival; Mortality;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Radiology; Ultrasonography; Magnetic resonance imaging; Radionuclide imaging; Positron emission tomography
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Neoplasm metastasis; Prostatectomy; Chemotherapy; Survival;
Keywords: نئوپلاسم پروستات; prostatectomy; risk; prostatic neoplasms; biopsy; watchful waiting; EPE; extraprostatic extension; GS; Gleason score; IPBx; initial prostate biopsy; LR; low risk; NCCN®; National Comprehensive Cancer Network®; PCa; prostate cancer; PSA; prostate specifi
Keywords: نئوپلاسم پروستات; watchful waiting; prostatic neoplasms; eligibility determination; AS; active surveillance; B2; confirmatory biopsy (second biopsy); BCR; biochemical recurrence; GS; Gleason score; JH; Johns Hopkins; MSK; Memorial Sloan Kettering Cancer Center; PCa; prosta
Keywords: نئوپلاسم پروستات; prostatic neoplasms; neoplasm grading; tumor burden; neoplasm invasiveness; watchful waiting; AS; active surveillance; BCR; biochemical recurrence; EPE; extraprostatic extension; GG; Grade Group; GS; Gleason score; PCa; prostate cancer; PSA; prostate spec